Trial
NCT01818999
Ixabepilone and SBRT For Metastatic Breast Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
METASTATIC BREAST CANCER
Intervention
IXABEPILONE
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-20